These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 38848833)
1. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma. Li A; Zhang K; Zhou J; Li M; Fan M; Gao H; Ma R; Gao L; Chen M Int J Biol Macromol; 2024 Jun; 272(Pt 2):132797. PubMed ID: 38848833 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma. Zhang L; Wang S; Wang L BMC Cancer; 2024 Oct; 24(1):1235. PubMed ID: 39375639 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma. Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484 [TBL] [Abstract][Full Text] [Related]
5. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration. Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975 [TBL] [Abstract][Full Text] [Related]
6. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma. Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071 [TBL] [Abstract][Full Text] [Related]
7. SGO2 as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma. Chen Y; Xiang T Front Biosci (Landmark Ed); 2024 Aug; 29(9):314. PubMed ID: 39344317 [TBL] [Abstract][Full Text] [Related]
8. Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases proliferation and migration of lung cancer cells. Ma W; Hu J Genes Genomics; 2024 Jun; 46(6):713-731. PubMed ID: 38064156 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value and molecular mechanisms of OAS1 in lung adenocarcinoma. Wang L; Gao L; Ding F; Gao K; Liu Q; Yin X BMC Pulm Med; 2024 Sep; 24(1):473. PubMed ID: 39334033 [TBL] [Abstract][Full Text] [Related]
10. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma. Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605 [TBL] [Abstract][Full Text] [Related]
11. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis. Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546 [TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma. Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886 [TBL] [Abstract][Full Text] [Related]
13. CRTAC1 identified as a promising diagnosis and prognostic biomarker in lung adenocarcinoma. Tan L; Zhang H; Ding Y; Huang Y; Sun D Sci Rep; 2024 May; 14(1):11223. PubMed ID: 38755183 [TBL] [Abstract][Full Text] [Related]
14. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
15. NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma. Chen X; Zhang T; He YQ; Miao TW; Yin J; Ding Q; Yang M; Chen FY; Zeng HP; Liu J; Zhu Q BMC Pulm Med; 2024 May; 24(1):248. PubMed ID: 38764064 [TBL] [Abstract][Full Text] [Related]
16. High TLX1 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Lung Adenocarcinoma. Zhao L; Zheng H; Chen F; Lu H; Yu Q; Yan X; Chen X; Zhang Q; Bu Q Curr Mol Med; 2024; 24(6):801-812. PubMed ID: 37340746 [TBL] [Abstract][Full Text] [Related]
17. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma. Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692 [TBL] [Abstract][Full Text] [Related]
18. NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle Wu P; Zhao L; Zhang H; Lou Y; Chen D; Xue S; Liu X; Jiang H Oncol Res; 2024; 32(9):1439-1452. PubMed ID: 39220139 [TBL] [Abstract][Full Text] [Related]
19. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma. Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453 [TBL] [Abstract][Full Text] [Related]
20. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]